A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.

2-ethyl-4-methylimidazole

CAS931-36-2
EC213-234-5

List details

Basic info

Status Intention
Submitter Norway
Remarks Read-across to other imidazoles.

Classification

Proposed harmonised classification by the dossier submitter
  • Germ cell mutagenicity
  • Carcinogenicity
  • Reproductive toxicity

Intention timeline

Date of intention 2019-01-10
Expected date of submission 2019-12-31

Documents

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

April 9, 2019
  • Expected date of submission: 2019-12-312020-12-31
May 7, 2019
  • Regulatory programme: Chemical registered under REACH
Jan. 13, 2021
  • Expected date of submission: 2020-12-312022-12-31
This version
Add the related substance to your watchlist to monitor this regulatory record.